Telix Pharmaceuticals Limited (TLPPF)
OTCMKTS · Delayed Price · Currency is USD
7.00
-0.10 (-1.41%)
Feb 5, 2026, 4:00 PM EST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $2.34 billion as of February 6, 2026. Its market cap has decreased by -58.61% in one year.
Market Cap
2.34B
Enterprise Value
2.56B
Revenue
664.23M
Ranking
n/a
PE Ratio
215.70
Stock Price
$7.00
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 115.28M to 2.34B, an increase of 1,929.17%. That is a compound annual growth rate of 44.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 2.39B | -5.55% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.55M |
| CytoDyn | 313.55M |
| Silence Therapeutics | 213.50M |
| Vaxart | 149.51M |
| BioStem Technologies | 112.90M |
| Nuo Therapeutics | 78.22M |
| HST Global | 74.26M |
| VitaSpring Biomedical | 51.78M |